|
Volumn 47, Issue 7, 2008, Pages 765-767
|
Contact pemphigus: A side-effect of imiquimod therapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CLOBETASOL PROPIONATE;
DESMOGLEIN 1 ANTIBODY;
DESMOGLEIN 3 ANTIBODY;
HLA DQ1 ANTIGEN;
HLA DR ANTIGEN;
HLA DR14 ANTIGEN;
HLA DR7 ANTIGEN;
IMIQUIMOD;
METHYLPREDNISOLONE;
PREDNISONE;
VIRUS DNA;
ACANTHOLYSIS;
ACANTHOSIS;
ADULT;
ANTIBODY DETECTION;
CASE REPORT;
CONTACT DERMATITIS;
DRUG WITHDRAWAL;
FEMALE;
HLA TYPING;
HUMAN;
HUMAN TISSUE;
IMMUNOFLUORESCENCE MICROSCOPY;
LETTER;
MORNING DOSAGE;
PAPILLOMATOSIS;
PEMPHIGUS;
POLYMERASE CHAIN REACTION;
REMISSION;
SKIN ABSCESS;
SKIN BIOPSY;
WART VIRUS;
ADMINISTRATION, TOPICAL;
AMINOQUINOLINES;
AZATHIOPRINE;
BIOPSY, NEEDLE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG THERAPY, COMBINATION;
FEMALE;
FLUORESCENT ANTIBODY TECHNIQUE, DIRECT;
FOLLOW-UP STUDIES;
HUMANS;
IMMUNOHISTOCHEMISTRY;
METHYLPREDNISOLONE;
MIDDLE AGED;
PAPILLOMAVIRIDAE;
PAPILLOMAVIRUS INFECTIONS;
PEMPHIGUS;
PREDNISONE;
RISK ASSESSMENT;
TREATMENT OUTCOME;
VULVAR DISEASES;
|
EID: 47649107703
PISSN: 00119059
EISSN: 13654632
Source Type: Journal
DOI: 10.1111/j.1365-4632.2008.03533.x Document Type: Letter |
Times cited : (19)
|
References (5)
|